期刊文献+

口服氟尿嘧啶类药物治疗大肠癌进展 被引量:8

原文传递
导出
摘要 氟尿嘧啶类药物在大肠癌治疗中占有十分重要的地位。口服氟尿嘧啶类药物与传统治疗方案中常用的5-氟尿嘧啶(5-FU)相比具有疗效高、毒性低、使用方便等优点,为治疗大肠癌提供了新的选择。现综述口服氟尿嘧啶类药物在治疗大肠癌中的研究进展。
出处 《国际肿瘤学杂志》 CAS 2006年第4期297-299,共3页 Journal of International Oncology
  • 相关文献

参考文献17

  • 1Douillard JY, Hoff PM, Skillings JR, et al. Muhicenter phase Ⅲ study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic coloreetal cancer. J Clin Oncol,2002,20( 17 ) :3605-3616.
  • 2Carmichael J, Popiela T, Radstone D, et al. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol,2002, 20(17) :3617-3627.
  • 3Feliu J, Vicent JM, Garcia Giron C, et al, Phase Ⅱ study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer. Br J Cancer,2004,91 (10) :1758-1762.
  • 4Schoffski P. The modulated oral fluoropyrimidine prodrug S- 1, and its use in gastrointestinal cancer and other solid tumors. Anticancer Drugs,2004,15 (2) :85-106.
  • 5Hoff PM,Saad ED,Ajani JA,et al. Phase Ⅰ study with pharmacokinetics of S- 1 on an oral daily schedule for 28 days in patients with solid tumors. Clin Cancer Res,2003,9(1) :134-142.
  • 6Van den Brande J,Schoffski P, Schellens J H, et al. EORTC Early Clinical Studies Group early phase Ⅱ trial of S-1 in patients with advanced or metastatic colorectal cancer. Br J Cancer,2003,88(5 ) :648-653.
  • 7Schilsky RL, Levin J, West WH, et al. Randomized, open-label, phase Ⅲ study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovofin as first-line therapy in patients with metastatic/advanced colorectal cancer. J Clin Oncol,2002,20(6 ) :1519-1526.
  • 8Hoff PM, Cassidy J, Schmoll HJ. The evolution of fluoropyrimidine therapy : from intravenous to oral. O neologist, 2001,6 ( Suppl 4 ) : 3 - 11.
  • 9Bajetta E,Colleoni M, Di Bartolomeo M, et al. Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer. J Clin Oneol,1995,13(10) : 2613-2619.
  • 10Ahn JH, Kim TW, Lee JH, et al. Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase Ⅱ trial with intravenous 5-fluorouracil plus leucovorin. Am J Clin Oncol, 2003,26 ( 1 ) :98-102.

同被引文献87

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部